CONGRESS FOR VOTERS

DemocratAmendment · S.Amdt. 2945· Senate(119-SAMDT-2945)

S.Amdt. 2945

Rep. Cortez Masto
Age: 62 years
Nevada
Introduced
7/17/2025
Sponsored by
Catherine Cortez Masto
Cosponsors
Democrat - 0Republican - 1
Changes bill
119-S-2296 — National Defense Authorization Act for Fiscal Year 2026
  1. Introduced
  2. Pending Consideration

What this amendment would do

This amendment aims to combat illicit xylazine by adding it to the Controlled Substances Act.

Purpose and Changes

  • Classification: It adds xylazine, including its salts and isomers, to Schedule III of the Controlled Substances Act.

  • Definitions: It defines an "ultimate user" for xylazine as a person who received the substance from a registered veterinarian or pharmacy and possesses it for animals they own or care for, or for authorized government animal-control and wildlife programs.

  • Operational Adjustments:

    • Manufacturers are not required to pay for security standard capital expenditures.
    • Labeling and distribution logistics requirements are delayed for 1 year.
    • Practitioner registration and recordkeeping requirements are delayed for 60 days.
    • The FDA and DEA must help speed up manufacturer applications.

  • Legal and Oversight Measures:

    • It updates the Arcos Tracking system to include xylazine.
    • The United States Sentencing Commission must review and potentially amend penalties for offenses involving xylazine.
    • The Attorney General must submit two reports to Congress: one within 18 months regarding the prevalence, origin, and diversion of illicit xylazine, and an update report within 4 years.